These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 24818765)

  • 1. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.
    Lin YW; Wong J; Qu L; Chan HK; Zhou QT
    Curr Pharm Des; 2015; 21(27):3902-16. PubMed ID: 26290193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How can we bring high drug doses to the lung?
    Claus S; Weiler C; Schiewe J; Friess W
    Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrostatics of Pharmaceutical Aerosols for Pulmonary Delivery.
    Lip Kwok PC
    Curr Pharm Des; 2015; 21(27):3945-54. PubMed ID: 26290198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation techniques for high dose dry powders.
    Brunaugh AD; Smyth HDC
    Int J Pharm; 2018 Aug; 547(1-2):489-498. PubMed ID: 29778822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
    Muralidharan P; Hayes D; Mansour HM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry powder inhalers for pulmonary drug delivery.
    Frijlink HW; De Boer AH
    Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-use disposable dry powder inhalers for pulmonary drug delivery.
    Friebel C; Steckel H
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1359-72. PubMed ID: 21080859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a novel dry powder inhaler.
    Zhang X; Ma Y; Zhang L; Zhu J; Jin F
    Int J Pharm; 2012 Jul; 431(1-2):45-52. PubMed ID: 22543053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dispersion behaviour of dry powder inhalation formulations cannot be assessed at a single inhalation flow rate.
    Grasmeijer F; de Boer AH
    Int J Pharm; 2014 Apr; 465(1-2):165-8. PubMed ID: 24548720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propellant-driven metered-dose inhalers for pulmonary drug delivery.
    Smyth HD
    Expert Opin Drug Deliv; 2005 Jan; 2(1):53-74. PubMed ID: 16296735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
    Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
    Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel alternatives to reduce powder retention in the dry powder inhaler during aerosolization.
    Heng D; Lee SH; Ng WK; Chan HK; Kwek JW; Tan RB
    Int J Pharm; 2013 Aug; 452(1-2):194-200. PubMed ID: 23680726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of device resistance and inhalation flow rate on the lung deposition of orally inhaled mannitol dry powder.
    Yang MY; Verschuer J; Shi Y; Song Y; Katsifis A; Eberl S; Wong K; Brannan JD; Cai W; Finlay WH; Chan HK
    Int J Pharm; 2016 Nov; 513(1-2):294-301. PubMed ID: 27639621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic Inhaler.
    Parumasivam T; Leung SS; Tang P; Mauro C; Britton W; Chan HK
    AAPS J; 2017 Jan; 19(1):191-202. PubMed ID: 27679516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.